South and Central America Non-Invasive Aesthetic Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Procedure (Injectables, Skin Rejuvenation, and Others) and End User (Hospitals, Clinics and Medical Spas, and Others)

TIPRE00023344 | Pages: 137 | Pharmaceuticals | Jul 2021 | Type: Regional | Status: Published

Market Introduction

Non-invasive or non-surgical aesthetic treatment refers to the aesthetic procedures that does not require any kind of surgical incision. Sometimes, minimally invasive surgeries are also considered as non-surgical procedures. Some of the commonly conducted non-invasive aesthetic treatment includes botulinum toxin injection, chemical peels, non-surgical laser treatment, and microdermabrasion amongst other.

 


Get more information on this report :



Market Overview and Dynamics

The South and Central America non-invasive aesthetic treatment market is expected to reach US$ 542.91 million by 2028 from US$ 274.29 million in 2021; it is estimated to grow at a CAGR of 10.2% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as rising number of non-invasive aesthetic/cosmetic procedures performed every year and surging awareness about cosmetic procedures among consumers. However, clinical risks and complications associated with medical aesthetic procedures is hindering the market growth.

Non-invasive aesthetic treatments have gained popularity in the past few years due to advantages such as minimal downtime, no scars, low cost, and less complications. The popularity and acceptance of these procedures is mainly attributed to their noninvasiveness. Besides, it has been proved that the accuracy rate of minimally invasive surgeries is greater than that of open surgeries. Therefore, the advantages of minimally invasive procedures over conventional surgery—such as faster recovery, reduced pain, and shortened hospital stays, and greater efficiency rate—contribute to the non-invasive aesthetic treatment market growth.  According to a recent report by the International Society of Aesthetic Plastic Surgery (2018), the total number of non-surgical procedures performed globally was above 12 million in 2018. The advancements in nonsurgical technologies and unveiling of new surgery options have made aesthetics accessible to people. For example, the advantages of laser procedures have attracted younger people to improve their skin conditions, modify body parts, and correct their physical posture. Therefore, rising acceptance of non-invasive aesthetic/cosmetic procedures is driving the growth of the South and Central America non-invasive aesthetic treatment market. Several government initiatives are helping in creating awareness regarding non-invasive aesthetic procedures among people, which is also boosting the market growth.

South and Central America is highly affected due to the COVID-19 outbreak pandemic. The outbreak has severely impacted the flow of medical services and medical tourism in the region. The Division of Plastic Surgery in Latin America suspended nonessential operations and outpatient consultations, achieving new guidelines (ANG) of national and international associations. Moreover, countries in this region are significantly dependent on the US and European countries for medical resources, which are under lockdown. Thus, the South and Central America non-invasive aesthetic treatment market in the region has experienced a significant slowdown and is expected to witness the same in the following two to three years.

 

Key Market Segments

The South and Central America non-invasive aesthetic treatment market, based on procedure, is segmented into injectables, skin rejuvenation, and others. The injectables segment held the largest share of the market in 2020, and the market for the same segment is expected to grow at the fastest rate during the forecast period.

The South and Central America non-invasive aesthetic treatment market, by end user, is segmented into hospitals, clinics and medical spas, and others. The hospitals segment held the largest share of the market in 2020. Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the South and Central America non-invasive aesthetic treatment market are the American Society for Aesthetic Plastic Surgery (ASAPS), Centers for Disease Control and Prevention (CDC) and National Health Service (NHS).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of South and Central America non-invasive aesthetic treatment market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the South and Central America non-invasive aesthetic treatment market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the South and Central America non-invasive aesthetic treatment market.

 

SOUTH AND CENTRAL AMERICA NON-INVASIVE AESTHETIC TREATMENT MARKET SEGMENTATION

By Procedure

  • Injectables
    • Botulinum Toxin
    • Calcium Hydroxylapatite
    • Hyaluronic Acid
    • Polymer Filler
    • Collagen
  • Skin Rejuvenation
    • Chemical Peel
    • Laser Skin Resurfacing
    • Photorejuvenation
  • Others
    • Hair Removal
    • Nonsurgical Fat Reduction
    • Sclerotherapy
    • Cellulite Treatment

By End User

  • Hospitals
  • Clinics and Medical Spas
  • Others

By Country

  • Brazil
  • Argentina
  • Rest of South and Central America

Company Profiles

  • Galderma
  • Alma Lasers
  • Merz Pharma
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • AbbVie Inc.
  • Candela Medical
  • Johnson and Johnson Services, Inc.
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America Non-invasive Aesthetic Treatment Market – By Procedure

1.3.2        South and Central America Non-invasive Aesthetic Treatment Market – By End User

1.3.3        South and Central America Non-invasive Aesthetic Treatment Market – By Country

2.           Non-invasive Aesthetic Treatment Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Non-invasive Aesthetic Treatment Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America

4.3         Expert Opinion

5.           Non-Invasive Aesthetic Treatment Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Number of Non-Invasive Aesthetic/Cosmetic Procedures Performed Every Year

5.1.2        Surge in Awareness About Cosmetic Procedures Among Consumers

5.1.3        Availability of Technologically Advanced Products

5.2         Market Restraints

5.2.1        Clinical Risks and Complications Associated with Medical Aesthetic Procedures

5.3         Market Opportunities

5.3.1        1.3.1 Technological Upgrades and Proliferation of Medical Tourism

5.4         Future Trends

5.4.1        Integration of Telemedicine with Medical Aesthetic Treatment

5.5         Impact Analysis

6.           Non-invasive Aesthetic Treatment Market – South and Central America Analysis

6.1         South and Central America Non-invasive Aesthetic Treatment Market Revenue Forecast and Analysis

7.           Non-invasive Aesthetic Treatment Market Analysis – By Procedure

7.1         Overview

7.2         Non-invasive Aesthetic Treatment Market, by Diagnosis 2020 & 2028 (%)

7.3         Injectables

7.3.1        Overview

7.3.2        Injectables: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Botulinum Toxin

7.3.3.1          Overview

7.3.3.2          Botulinum Toxin: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Calcium Hydroxylapatite

7.3.4.1          Overview

7.3.4.2          Calcium hydroxylapatite: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Hyaluronic Acid

7.3.5.1          Overview

7.3.5.2          Hyaluronic Acid: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6        Polymer

7.3.6.1          Overview

7.3.6.2          Polymer: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.3.7        Collagen

7.3.7.1          Overview

7.3.7.2          Collagen: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Skin Rejuvenation

7.4.1        Overview

7.4.2        Skin Rejuvenation: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Chemical Peels

7.4.3.1          Overview

7.4.3.2          Chemical Peels: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Laser Skin Resurfacing

7.4.4.1          Overview

7.4.4.2          Laser Skin Resurfacing: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5        Photorejuvenation

7.4.5.1          Overview

7.4.5.2          Photorejuvenation: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Others

7.5.1        Overview

7.5.2        Others: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3        Hair Removal

7.5.3.1          Overview

7.5.3.2          Hair Removal: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4        Nonsurgical Fat Reduction

7.5.4.1          Overview

7.5.4.2          Nonsurgical Fat Reduction: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5        Sclerotherapy

7.5.5.1          Overview

7.5.5.2          Sclerotherapy: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

7.5.6        Cellulite Treatment

7.5.6.1          Overview

7.5.6.2          Cellulite Treatment: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.           Non-invasive Aesthetic Treatment Market Analysis – By End User

8.1         Overview

8.2         Non-invasive Aesthetic Treatment Market Revenue Share, by End User (2020 and 2028)

8.3         Hospitals

8.3.1        Overview

8.3.2        Hospitals: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Clinics and Medical Spas

8.4.1        Overview

8.4.2        Clinics and Medical Spas: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

9.           Non-invasive Aesthetic Treatment Market – South and Central America Analysis

9.1         South and Central America: Non-invasive Aesthetic Treatment Market

9.1.1        Overview

9.1.2        South and Central America: Non-invasive Aesthetic Treatment Market, by Country, 2020 & 2028 (%)

9.1.2.1          Brazil: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.1          Brazil: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2          Brazil: Non-invasive Aesthetic Treatment Market, by Procedure - Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2.1        Brazil: Non-invasive Aesthetic Treatment Market, by Injectables - Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2.2        Brazil: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation - Revenue and Forecast to 2028 (USD Million)

9.1.2.1.2.3        Brazil: Non-invasive Aesthetic Treatment Market, by Others - Revenue and Forecast to 2028 (USD Million)

9.1.2.1.3          Brazil: Non-invasive Aesthetic Treatment Market, by End User - Revenue and Forecast to 2028 (USD Million)

9.1.2.2          Argentina: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1          Argentina: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2          Argentina: Non-invasive Aesthetic Treatment Market, by Procedure - Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2.1        Argentina: Non-invasive Aesthetic Treatment Market, by Injectables - Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2.2        Argentina: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation - Revenue and Forecast to 2028 (USD Million)

9.1.2.2.2.3        Argentina: Non-invasive Aesthetic Treatment Market, by Others - Revenue and Forecast to 2028 (USD Million)

9.1.2.2.3          Argentina: Non-invasive Aesthetic Treatment Market, by End User - Revenue and Forecast to 2028 (USD Million)

9.1.2.3          Rest of South and Central America: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1          Rest of South and Central America: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Procedure - Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2.1        Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Injectables - Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2.2        Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation - Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2.3        Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Others - Revenue and Forecast to 2028 (USD Million)

9.1.2.3.3          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by End User - Revenue and Forecast to 2028 (USD Million)

10.        Impact Of COVID-19 Pandemic on South and Central America Non-invasive Aesthetic Treatment Market

10.1      South and Central America: Impact Assessment of COVID-19 Pandemic

11.        Non-invasive Aesthetic Market–Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      Galderma

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Alma Lasers

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Merz Pharma

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Bausch Health Companies Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Cutera Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      AbbVie Inc.

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Candela Medical

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      Johnson and Johnson Services, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             Brazil: Non-invasive Aesthetic Treatment Market, by Procedure – Revenue and Forecast to 2028 (USD Million)

Table 2.             Brazil: Non-invasive Aesthetic Treatment Market, by Injectables – Revenue and Forecast to 2028 (USD Million)

Table 3.             Brazil: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation – Revenue and Forecast to 2028 (USD Million)

Table 4.             Brazil: Non-invasive Aesthetic Treatment Market, by Others – Revenue and Forecast to 2028 (USD Million)

Table 5.             Brazil: Non-invasive Aesthetic Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 6.             Argentina: Non-invasive Aesthetic Treatment Market, by Procedure – Revenue and Forecast to 2028 (USD Million)

Table 7.             Argentina: Non-invasive Aesthetic Treatment Market, by Injectables – Revenue and Forecast to 2028 (USD Million)

Table 8.             Argentina: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation – Revenue and Forecast to 2028 (USD Million)

Table 9.             Argentina: Non-invasive Aesthetic Treatment Market, by Others – Revenue and Forecast to 2028 (USD Million)

Table 10.          Argentina: Non-invasive Aesthetic Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 11.          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Procedure – Revenue and Forecast to 2028 (USD Million)

Table 12.          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Injectables – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Skin Rejuvenation – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by Others – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of South and Central America: Non-invasive Aesthetic Treatment Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 16.          Recent Inorganic Growth Strategies in the of Non-Invasive Aesthetic Treatment Market

Table 17.          Recent Organic Growth Strategies in the Non-invasive Aesthetic Treatment Market

Table 18.          Glossary of Terms, Non-invasive Aesthetic Treatment Market

LIST OF FIGURES

Figure 1.           Non-invasive Aesthetic Treatment Market Segmentation

Figure 2.           Non-invasive Aesthetic Treatment Market, By Country

Figure 3.           South and Central America Non-invasive Aesthetic Treatment Market Overview

Figure 4.           Injectable Segment Held Largest Share of the Market by Procedure

Figure 5.           South and Central America Non-invasive Aesthetic Treatment Market- Leading Country Markets (USD Million)

Figure 6.           South & Central America PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Non-invasive Aesthetic Treatment Market Impact Analysis of Drivers and Restraints

Figure 9.           South and Central America Non-invasive Aesthetic Treatment Market – Revenue Forecast and Analysis – 2019- 2028

Figure 10.        Non-invasive Aesthetic Treatment Market, by Diagnosis 2020 & 2028 (%)

Figure 11.        Injectables: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Botulinum Toxin: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Calcium hydroxylapatite: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Hyaluronic Acid: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Polymer: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Collagen: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Skin Rejuvenation: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Chemical peels: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Laser Skin Resurfacing: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Photorejuvenation: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Others: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Hair Removal: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Nonsurgical Fat Reduction: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Sclerotherapy: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Cellulite Treatment: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Non-invasive Aesthetic Treatment Market Revenue Share, by End User (2020 and 2028)

Figure 27.        Hospitals: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Clinics and Medical Spas: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Others: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        South and Central America: Non-invasive Aesthetic Treatment Market, by Key Country – Revenue (2020) (USD Million)

Figure 31.        South and Central America: Non-invasive Aesthetic Treatment Market, by Country, 2020 & 2028 (%)

Figure 32.        Brazil: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 33.        Argentina: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 34.        Rest of South and Central America: Non-invasive Aesthetic Treatment Market – Revenue and Forecast to 2028 (USD Million)

Figure 35.        Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets

 

 

 

  • Galderma
  • Alma Lasers
  • Merz Pharma
  • Bausch Health Companies Inc.
  • Cutera Inc.
  • AbbVie Inc.
  • Candela Medical
  • Johnson and Johnson Services, Inc.

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America non-invasive aesthetic treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South and Central America non-invasive aesthetic treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000